Hyaluronic Acid Induces Survival and Proliferation of Human Myeloma Cells through an Interleukin-6-mediated Pathway Involving the Phosphorylation of Retinoblastoma Protein
Open Access
- 1 January 2001
- journal article
- Published by Elsevier BV
- Vol. 276 (18), 14728-14736
- https://doi.org/10.1074/jbc.m003965200
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- TNF-α Induction of CD44-Mediated Leukocyte Adhesion by SulfationScience, 1998
- Multiple MyelomaNew England Journal of Medicine, 1997
- Differential human multiple myeloma cell line responsiveness to interferon-alpha. Analysis of transcription factor activation and interleukin 6 receptor expression.JCI Insight, 1997
- Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progressionCurrent Opinion in Cell Biology, 1997
- Interleukin‐6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti‐gp130 monoclonal antibodiesEuropean Journal of Immunology, 1995
- Interleukin-6 Inhibits Apoptosis of Malignant Plasma CellsCellular Immunology, 1995
- G1 phase progression: Cycling on cueCell, 1994
- Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein.The Journal of Experimental Medicine, 1992
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- Regulation of Hemopoiesis by Bone Marrow Stromal Cells and Their ProductsAnnual Review of Immunology, 1990